Skip to Content

Resorcinol / sulfur topical Pregnancy and Breastfeeding Warnings

Resorcinol / sulfur topical is also known as: Acnomel, Acnotex, Bensulfoid, Rezamid, Sulforcin

Resorcinol / sulfur topical Pregnancy Warnings

Animal studies have not been reported. There are no controlled data in human pregnancy.

The manufacturer makes no recommendation regarding use during pregnancy.

AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: Not formally assigned to a pregnancy category.

See references

Resorcinol / sulfur topical Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments:
-The effects in the nursing infant are unknown.
-LactMed: Sulfur 5% to 10% in a petrolatum base is considered safe for topical use in children (including infants younger than 2 months).

See references

References for pregnancy information

  1. "Product Information. Bensulfoid (resorcinol-sulfur topical)." ECR Pharmaceuticals, Richmond, VA.

References for breastfeeding information

  1. "Product Information. Bensulfoid (resorcinol-sulfur topical)." ECR Pharmaceuticals, Richmond, VA.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide